Linkage of the dopamine receptor D1 gene to attention-deficit/hyperactivity disorder

Molecular Psychiatry

Volumn 9, Issue 5, 2004, Pages 500-509

  Misener, V L ^a   Luca, P ^a   Azeke, O ^a   Crosbie, J ^b   Waldman, I ^c   Tannock, R ^b   Roberts, W ^b   Malone, M ^b   Schachar, R ^b   Ickowicz, A ^b   Kennedy, J L ^d   Barr, C L ^a,b,e  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Attention deficit hyperactivity disorder; Dopamine receptor D1; Genetics; Linkage; Transmission disequilibrium test

Indexed keywords

DNA; DOPAMINE 1 RECEPTOR;

ADOLESCENT; ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; DNA DETERMINATION; FEMALE; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOTE; HUMAN; HYPERACTIVITY; IMPULSIVENESS; INHERITANCE; MALE; MARKER GENE; PRIORITY JOURNAL; QUANTITATIVE TRAIT; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; IMPULSIVE BEHAVIOR; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D1;

EID: 3142628101     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001440     Document Type: Article

References (86)

1. Thapar A, Holmes J, Poulton K, Harrington R. Genetic basis of attention deficit and hyperactivity. Br J Psychiatry 1999; 174: 105-111.
2. Faraone SV, Biederman J. Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry 1998; 44: 951-958.
3. Barr CL, Swanson JM, Kennedy JL. Molecular genetics of ADHD. In: Levy F, Hay D (eds) Attention, Genes and ADHD. Taylor and Francis Inc.: Philadelphia, PA, 2001, pp 173-195.
4. Gillis JJ, Gilger JW, Pennington BF, DeFries JC. Attention deficit disorder in reading-disabled twins: evidence for a genetic etiology. J Abnormal Child Psychol 1992; 20: 303-315.
5. Thapar A, Hervas A, McGuffin P. Childhood hyperactivity scores are highly heritable and show sibling competition effects: twin study evidence. Behav Genet 1995; 25: 537-544.
6. Gjone H, Stevenson J, Sundet JM. Genetic influence on parent-reported attention-related problems in a Norwegian general population twin sample. J Am Acad Child Adolesc Psychiatry 1996; 35: 588-596.
7. Levy F, Hay DA, McStephen M, Wood C, Waldman I. Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry 1997; 36: 737-744.
8. Sherman DK, Iacono WG, McGue MK. Attention-deficit hyperactivity disorder dimensions: a twin study of inattention and impulsivity-hyperactivity. J Am Acad Child Adolesc Psychiatry 1997; 36: 745-753.
9. Seeman P, Madras BK. Anti-hyperactivity medication: methylphenidate and amphetamine. Mol Psychiatry 1998; 3: 386-396.
10. Levy F. The dopamine theory of attention deficit hyperactivity disorder (ADHD). Aust NZ J Psychiatry 1991; 25: 277-283.
11. Faraone SV, Doyle AE, Mick E, Biederman J. Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry 2001; 158: 1052-1057.
12. Maher BS, Marazita ML, Ferrell RE, Vanyukov MM. Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis. Psychiatr Genet 2002; 12: 207-215.
13. Wang HY, Undie AS, Friedman E. Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation. Mol Pharmacol 1995; 48: 988-994.
14. Jin LQ, Wang HY, Friedman E. Stimulated D(1) dopamine receptors couple to multiple Galpha proteins in different brain regions. J Neurochem 2001; 78: 981-990.
15. Jackson DM, Westlind-Danielsson A. Dopamine receptors: molecular biology, biochemistry and behavioural aspects. Pharmacol Ther 1994; 64: 291-370.
16. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopamine receptors: from structure to function. Physiol Rev 1998; 78: 189-225.
17. Arnsten AF, Steere JC, Hunt RD. The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1996; 53: 448-455.
18. Arnsten AFT. Dopaminergic and noradrenergic influences on cognitive functions mediated by prefrontal cortex. In: Solanto MV, Arnsten AFT, Castellanos FX (eds). Stimulant Drugs and ADHD. Basic and Clinical Neuroscience. Oxford University Press, Inc.: New York, NY, 2001, pp 185-208.
19. Denney CB, Rapport MD. Cognitive pharmacology of stimulants in children with ADHD. In: Solanto MV, Arnsten AFT, Castellanos FX (eds) Stimulant Drugs and ADHD. Basic and Clinical Neuroscience. Oxford University Press, Inc.: New York, NY, 2001, pp 283-302.
20. Castellanos FX. Neuroimaging studies of ADHD. In: Solanto MV, Arnsten AFT, Castellanos FX (eds). Stimulant Drugs and ADHD. Basic and Clinical Neuroscience. Oxford University Press, Inc.: New York, NY, 2001, pp 243-258.
21. Sawaguchi T, Goldman-Rakic PS. D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 1991; 251: 947-950.
22. Williams GV, Goldman-Rakic PS. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 1995; 376: 572-575.
23. Castellanos FX, Tannock R. Neuroscience of attention-deficit/ hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 2002; 3: 617-628.
24. de Fockert JW, Rees G, Frith CD, Lavie N. The role of working memory in visual selective attention. Science 2001; 291: 1803-1806.
25. Conway AR, Cowan N, Bunting MF. The cocktail party phenomenon revisited: the importance of working memory capacity. Psychon Bull Rev 2001; 8: 331-335.
26. Clifford JJ, Tighe O, Croke DT, Sibley DR, Drago J, Waddington JL. Topographical evaluation of the phenotype of spontaneous behaviour in mice with targeted gene deletion of the D1A dopamine receptor: paradoxical elevation of grooming syntax. Neuropharmacology 1998; 37: 1595-1602.
27. Xu M, Hu XT, Cooper DC, Moratalla R, Graybiel AM, White FJ et al. Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell 1994; 79: 945-955.
28. Xu M, Moratalla R, Gold LH, Hiroi N, Koob GF, Graybiel AM et al. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 1994; 79: 729-742.
29. Karasinska JM, George SR, El-Ghundi M, Fletcher PJ, O'Dowd BF. Modification of dopamine D(1) receptor knockout phenotype in mice lacking both dopamine D(1) and D(3) receptors. Eur J Pharmacol 2000; 399: 171-181.
30. Drago J, Gerfen CR, Lachowicz JE, Steiner H, Hollon TR, Love PE et al. Altered striatal function in a mutant mouse lacking D1A dopamine receptors. Proc Natl Acad Sci USA 1994; 91: 12564-12568.
31. Smith DR, Striplin CD, Geller AM, Mailman RB, Drago J, Lawler CP et al. Behavioural assessment of mice lacking D1A dopamine receptors. Neuroscience 1998; 86: 135-146.
32. Cromwell HC, Berridge KC, Drago J, Levine MS. Action sequencing is impaired in D1A-deficient mutant mice. Eur J Neurosci 1998; 10: 2426-2432.
33. Kadesjo B, Gillberg C. Attention deficits and clumsiness in Swedish 7-year-old children. Dev Med Child Neurol 1998; 40: 796-804.
34. Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 1997; 121: 65-94.
35. Sagvolden T. Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/ hyperactivity disorder (AD/HD). Neurosci Biobehav Rev 2000; 24: 31-39.
36. Russell VA. Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder - the spontaneously hypertensive rat. Behav Brain Res 2002; 130: 191-196.
37. Sadile AG. Multiple evidence of a segmental defect in the anterior forebrain of an animal model of hyperactivity and attention deficit. Neurosci Biobehav Rev 2000; 24: 161-169.
38. Amenta F, Ricci A, Rossodivita I, Avola R, Tayebati SK. The dopaminergic system in hypertension. Clin Exp Hypertens 2001; 23: 15-24.
39. Hussain T, Kansra V, Lokhandwala MF. Renal dopamine receptor signaling mechanisms in spontaneously hypertensive and Fischer 344 day old rats. Clin Exp Hypertens 1999; 21: 25-36.
40. Sagvolden T, Hendley ED, Knardahl S. Behavior of hypertensive and hyperactive rat strains: hyperactivity is not unitarily determined. Physiol Behav 1992; 52: 49-57.
41. Viggiano D, Vallone D, Welzl H, Sadile AG. The Naples High- and Low-Excitability rats: selective breeding, behavioral profile, morphometry, and molecular biology of the mesocortical dopamine system. Behav Genet 2002; 32: 315-333.
42. Barr CL, Wigg K, Malone M, Schachar R, Tannock R, Roberts W et al. Linkage study of catechol-O-methyltransferase and attention-deficit hyperactivity disorder. Am J Med Genet 1999; 88: 710-713.
43. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition. American Psychiatric Association: Washington, DC, 1994.
44. Wechsler DI. Examiner's Manual: Wechsler Intelligence Scale for Children - Third Edition. Psychological Corporation: New York, NY, 1991.
45. Ickowicz A, Schachar R, Sugarman R, Chen S, Millette C, Cook L et al. Reliability and validity of the Parent Interview for Child Symptoms (PICS), Paper Presented at 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, 2002##San Francisco, CA.
46. Tannock R, Hum M, Masellis M, Humphries T, Schachar R. Teacher Telephone Interview for Children's Academic Performance, Attention, Behaviour and Learning: DSM-IV Version (TTI-IV). The Hospital for Sick Children: Toronto, Canada, Unpublished document, 2002.
47. Conners CK. Conners' Rating Scales - Revised. Multi-Health Systems: Toronto, Canada, 1997.
48. Boyle MH, Offord DR, Racine Y, Fleming JE, Szatmari P, Sanford M. Evaluation of the revised Ontario Child Health Study scales. J Child Psychol Psychiatry 1993: 34: 189-213.
49. Wilkinson GS. Wide Range Achievement Test 3 - Revision 3. Jastak Associates: Wilmington, DE, 1993.
50. Semel E, Wing E, Secord W. Clinical Evaluation of Language Fundamentals - Third Edition (CELF-3). The Psychological Corporation: San Antonio, TX, 1995.
51. Kovacs M. Manual: The Children's Depression Inventory. Multi-Health Systems: Toronto, Canada, 1995.
52. Reynolds CR, Richmond BO. What I Think and Feel (RCMAS). Western Psychological Services: Los Angeles, CA, 1985.
53. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
54. Cichon S, Nothen MM, Erdmann J, Propping P. Detection of four polymorphic sites in the human dopamine D1 receptor gene (DRD1). Hum Mol Genet 1994; 3: 209.
55. Cichon S, Nothen MM, Stober G, Schroers R, Alhus M, Maier W et al. Systematic screening for mutations in the 5′-regulatory region of the human dopamine D1 receptor (DRD1) gene in patients with schizophrenia and bipolar affective disorder. Am J Med Genet 1996; 67: 424-428.
56. Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 1995; 29: 311-322.
57. Lewontin RC. The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 1964; 49: 49-67.
58. Ott J. Analysis of Human Genetic Linkage. The Johns Hopkins University Press: Baltimore, MD, 1991.
59. Sham PC, Curtis D. An extended transmission/disequilibrium test (TDT) for multi-allele marker loci. Ann Hum Genet 1995; 59: 323-336.
60. Clayton D. A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet 1999; 65: 1170-1177.
61. Curtis D, Sham PC. A note on the application of the transmission disequilibrium test when a parent is missing. Am J Hum Genet 1995; 56: 811-812.
62. Cervino AC, Hill AV. Comparison of tests for association and linkage in incomplete families. Am J Hum Genet 2000; 67: 120-132.
63. Laird NM, Horvath S, Xu X. Implementing a unified approach to family-based tests of association. Genet Epidemiol 2000; 19: S36-S42.
64. The FBAT Program v1.4.1##http://www.biostat.harvard.edu/ ~fbat/default.html.
65. Waldman ID, Robinson BF, Rowe DC. A logistic regression based extension of the TDT for continuous and categorical traits. Ann Hum Genet 1999; 63: 329-340.
66. Spielman RS, Ewens WJ. The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet 1996; 59: 983-989.
67. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-516.
68. Ewens WJ, Spielman RS. The transmission/disequilibrium test: history, subdivision, and admixture. Am J Hum Genet 1995; 57: 455-464.
69. Ewens WJ, Spielman RS. The transmission/disequilibrium test. In: Balding DJ (ed). Handbook of Statistical Genetics. John Wiley & Sons, Ltd.: New York, 2001, pp 507-518.
70. Wong AH, Buckle CE, Van Tol HH. Polymorphisms in dopamine receptors: what do they tell us? Eur J Pharmacol 2000; 410: 183-203.
71. Minowa MT, Minowa T, Mouradian MM. Activator region analysis of the human D1A dopamine receptor gene. J Biol Chem 1993; 268: 23544-23551.
72. Lee SH, Mouradian MM. Up-regulation of D1A dopamine receptor gene transcription by estrogen. Mol Cell Endocrinol 1999; 156: 151-157.
73. Neuman RJ, Todd RD, Heath AC, Reich W, Hudziak JJ, Bucholz KK et al. Evaluation of ADHD typology in three contrasting samples: a latent class approach. J Am Acad Child Adolesc Psychiatry 1999; 38: 25-33.
74. Stevenson J. Evidence for a genetic etiology in hyperactivity in children. Behav Genet 1992; 22: 337-344.
75. Goodman R, Stevenson J. A twin study of hyperactivity - II. The aetiological role of genes, family relationships and perinatal adversity. J Child Psychol Psychiatry 1989; 30: 691-709.
76. Kirley A, Hawi Z, Daly G, McCarron M, Mullins C, Millar N et al. Dopaminergic system genes in ADHD: toward a biological hypothesis. Neuropsychopharmacology 2002; 27: 607-619.
77. Daly G, Hawi Z, Fitzgerald M, Gill M. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry 1999; 4: 192-196.
78. Lahey BB, Applegate B, McBurnett K, Biederman J, Greenhill L, Hynd GW et al. DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry 1994; 151: 1673-1685.
79. Wolraich ML, Hannah JN, Pinnock TY, Baumgaertel A, Brown J. Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry 1996; 35: 319-324.
80. Feng J, Sobell JL, Heston LL, Cook Jr EH, Goldman D, Sommer SS. Scanning of the dopamine D1 and D5 receptor genes by REF in neuropsychiatric patients reveals a novel missense change at a highly conserved amino acid. Am J Med Genet 1998; 81: 172-178.
81. Thompson M, Comings DE, Feder L, George SR, O'Dowd BF. Mutation screening of the dopamine D1 receptor gene in Tourette's syndrome and alcohol dependent patients. Am J Med Genet 1998; 81: 241-244.
82. Fisher SE, Francks C, McCracken JT, McGough JJ, Marlow AJ, MacPhie IL et al. A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. Am J Hum Genet 2002; 70: 1183-1196.
83. Lidow MS, Roberts A, Zhang L, Koh PO, Lezcano N, Bergson C. Receptor crosstalk protein, calcyon, regulates affinity state of dopamine D1 receptors. Eur J Pharmacol 2001; 427: 187-193.
84. Lezcano N, Mrzljak L, Eubanks S, Levenson R, Goldman-Rakic P, Bergson C. Dual signaling regulated by calcyon, a D1 dopamine receptor interacting protein. Science 2000; 287: 1660-1664.
85. Minowa MT, Minowa T, Monsma Jr FJ, Sibley DR, Mouradian MM. Characterization of the 5′ flanking region of the human D1A dopamine receptor gene. Proc Natl Acad Sci USA 1992; 89: 3045-3049.
86. Lee SH, Minowa MT, Mouradian MM. Two distinct promoters drive transcription of the human D1A dopamine receptor gene. J Biol Chem 1996; 271: 25292-25299.